| General Information of Drug Metabolite (DM) (ID: DM019375) |
| DM Name |
T-0055
|
| Structure |
|
|
3D MOL is unavailable
|
2D MOL is unavailable
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Aldo-keto reductase 1A1 (AKR1A1)
|
DME0098
|
| Unclear - Unclear |
T-0128
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| T-0128 |
DR3140
|
Phase 1 |
Solid tumour/cancer |
|
|
| References |
| 1 |
Clinical and pharmacologic study of the novel prodrug delimotecan (MEN 4901/T-0128) in patients with solid tumors
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
